HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy.

Proceedings of the National Academy of Sciences of the United States of America
Samanthi A PereraKwok-Kin Wong

Abstract

Mutations in the HER2 kinase domain have been identified in human clinical lung cancer specimens. Here we demonstrate that inducible expression of the most common HER2 mutant (HER2(YVMA)) in mouse lung epithelium causes invasive adenosquamous carcinomas restricted to proximal and distal bronchioles. Continuous expression of HER2(YVMA) is essential for tumor maintenance, suggesting a key role for HER2 in lung adenosquamous tumorigenesis. Preclinical studies assessing the in vivo effect of erlotinib, trastuzumab, BIBW2992, and/or rapamycin on HER2(YVMA) transgenic mice or H1781 xenografts with documented tumor burden revealed that the combination of BIBW2992 and rapamycin is the most effective treatment paradigm causing significant tumor shrinkage. Immunohistochemical analysis of lung tumors treated with BIBW2992 and rapamycin combination revealed decreased phosphorylation levels for proteins in both upstream and downstream arms of MAPK and Akt/mTOR signaling axes, indicating inhibition of these pathways. Based on these findings, clinical testing of the BIBW2992/rapamycin combination in non-small cell lung cancer patients with tumors expressing HER2 mutations is warranted.

References

Aug 1, 1994·AJR. American Journal of Roentgenology·E A KazerooniT C McLoud
Mar 17, 2001·Nature Reviews. Molecular Cell Biology·Y Yarden, M X Sliwkowski
Mar 15, 2002·Seminars in Oncology·Christopher G AzzoliRobert Mass
Dec 18, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·U GatzemeierV Hirsh
Feb 26, 2004·Seminars in Oncology·Fred R Hirsch, Corey J Langer
Oct 1, 2004·Nature·Philip StephensMichael R Stratton
Oct 7, 2004·Trends in Molecular Medicine·Adi F GazdarJohn D Minna
Mar 9, 2005·Cancer Research·Hisayuki ShigematsuAdi F Gazdar
Jul 22, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeffrey A Engelman, Lewis C Cantley
Dec 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mayumi Ono, Michihiko Kuwano

❮ Previous
Next ❯

Citations

Jun 10, 2011·International Journal of Clinical Oncology·Kenichi SudaTetsuya Mitsudomi
Jan 12, 2013·Targeted Oncology·Nicolas Girard
Sep 4, 2012·Indian Journal of Surgical Oncology·R Vijayalakshmi, Arvind Krishnamurthy
Oct 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Martin L SosRoman K Thomas
Jul 19, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Takeshi ShimamuraGeoffrey I Shapiro
Jul 5, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maria E ArcilaMarc Ladanyi
Jan 26, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Katerina Politi, William Pao
Feb 13, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Geoffrey R OxnardPasi A Jänne
Jun 5, 2013·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Vladimira KoudelakovaMarian Hajduch
Dec 10, 2013·Journal of the National Cancer Institute·Geoffrey R OxnardDaniel B Costa
Mar 20, 2014·Naunyn-Schmiedeberg's Archives of Pharmacology·Helmout ModjtahediFlavio Solca
May 4, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Pilar GarridoJosé Javier Gómez
Oct 7, 2011·Science Translational Medicine·Phuoc T TranDean W Felsher
Apr 25, 2013·The Journal of Biological Chemistry·Ying-Xin FanGibbes R Johnson
Mar 13, 2012·Expert Opinion on Therapeutic Patents·Giovanni MarzaroAdriana Chilin
Nov 25, 2014·Expert Review of Anticancer Therapy·Prantesh JainNeelesh Sharma
Jan 19, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Geoffrey R OxnardPasi A Jänne
Dec 24, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Daniel MorgenszternRamaswamy Govindan
Sep 24, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Giuseppina Rosaria Rita RicciardiVincenzo Adamo
Jul 3, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Chien-Hung GowJin-Yuan Shih
Dec 16, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Lingxiang LiuYongqian Shu
Aug 26, 2015·Journal of Cellular and Molecular Medicine·Zijia SunXiaoxiang Guan
Nov 29, 2011·Cancer Treatment Reviews·Jean-Charles SoriaPasi A Jänne
Nov 8, 2011·Clinics in Chest Medicine·Jill E Larsen, John D Minna
Mar 1, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Kenji TomizawaTetsuya Mitsudomi
Jun 17, 2015·Revue des maladies respiratoires·D RouviereJ Mazieres
Mar 12, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Daniel B CostaSusumu S Kobayashi
Jul 22, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Eckart LaackCarsten Bokemeyer
Feb 14, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·J De GrèveD Schallier
Aug 13, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Heounjeong GoYoung Tae Kim
Feb 16, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Jacques De GrèveJohan Vansteenkiste
Jan 21, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Nataliya MarJeffrey S Wasser
Feb 13, 2015·Frontiers in Oncology·Xiaochun WangJia-Lin Yang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.